Foot Procedures without CC/MCC DRG Reimbursement Guide

DRG 505 addresses inpatient admissions for foot procedures without Complication or Comorbidity or Major Complication or Comorbidity and encompasses non-complex surgical foot interventions that have relatively lower resource use. Proper classification into this Diagnosis-Related Group affects Medicare inpatient reimbursement by aligning the bundled payment with the expected intensity of care.

DRG 505 Overview

DRG 505 covers inpatient admissions for foot procedures without a Complication or Comorbidity or Major Complication or Comorbidity, typically including surgical debridement, bunionectomy, toe amputations, and other non-complex foot operations. This Diagnosis-Related Group groups cases with lower expected resource use compared with foot procedures that have additional comorbid conditions. It matters for Medicare payment because hospitals are reimbursed a bundled amount for the admission based on the assigned Diagnosis-Related Group, which reflects anticipated costs and drives inpatient reimbursement planning. Accurate clinical documentation and coding determine assignment to DRG 505 and the associated payment tier.

DRG 505 Overview

Perioperative analgesia and regional anesthesia trials: randomized studies comparing perioperative pain management strategies (for example, local nerve blocks versus systemic opioid-sparing multimodal regimens) in adults undergoing inpatient foot procedures without major complications. These trials enroll patients having common operative foot interventions such as bunionectomy, hammertoe correction, or forefoot reconstruction to evaluate pain scores, opioid consumption, and early functional recovery in the immediate postoperative period. Results are relevant to clinicians and payers because improved analgesia that reduces opioid use and shortens length of stay can lower inpatient costs and complications while supporting safe discharge planning.
Comparative effectiveness studies of surgical technique and fixation methods: prospective cohort or randomized studies that compare different operative approaches (for instance, minimally invasive versus open techniques, or various fixation devices and suture constructs) in patients with benign forefoot deformities or soft-tissue procedures treated without significant comorbidity. These studies measure complication rates, reoperation, time to weightbearing, and patient-reported functional outcomes over the short and intermediate term to determine which methods optimize recovery for otherwise low-risk inpatients. Findings inform surgeons, hospitals, and payers about which procedures and implants provide best value by balancing procedural costs, device utilization, and likelihood of readmission or downstream resource use.
Post-discharge functional outcomes and readmission risk prediction studies: observational registry-based research or pragmatic trials that track recovery trajectories, wound healing, and unplanned healthcare utilization after discharge for patients who had foot procedures without CC/MCC. Such studies focus on identifying predictors of delayed healing, wound complications, or emergency visits among heterogeneous patients (including older adults, diabetics with well-controlled disease, and those with limited social support) to guide follow-up intensity and home health needs. This area is important to providers and payers because targeting follow-up resources to patients at higher risk can reduce preventable readmissions and outpatient emergency care, improving outcomes while controlling post-acute costs.

Perioperative analgesia and regional anesthesia trials: randomized studies comparing perioperative pain management strategies (for example, local nerve blocks versus systemic opioid-sparing multimodal regimens) in adults undergoing inpatient foot procedures without major complications. These trials enroll patients having common operative foot interventions such as bunionectomy, hammertoe correction, or forefoot reconstruction to evaluate pain scores, opioid consumption, and early functional recovery in the immediate postoperative period. Results are relevant to clinicians and payers because improved analgesia that reduces opioid use and shortens length of stay can lower inpatient costs and complications while supporting safe discharge planning.
Comparative effectiveness studies of surgical technique and fixation methods: prospective cohort or randomized studies that compare different operative approaches (for instance, minimally invasive versus open techniques, or various fixation devices and suture constructs) in patients with benign forefoot deformities or soft-tissue procedures treated without significant comorbidity. These studies measure complication rates, reoperation, time to weightbearing, and patient-reported functional outcomes over the short and intermediate term to determine which methods optimize recovery for otherwise low-risk inpatients. Findings inform surgeons, hospitals, and payers about which procedures and implants provide best value by balancing procedural costs, device utilization, and likelihood of readmission or downstream resource use.
Post-discharge functional outcomes and readmission risk prediction studies: observational registry-based research or pragmatic trials that track recovery trajectories, wound healing, and unplanned healthcare utilization after discharge for patients who had foot procedures without CC/MCC. Such studies focus on identifying predictors of delayed healing, wound complications, or emergency visits among heterogeneous patients (including older adults, diabetics with well-controlled disease, and those with limited social support) to guide follow-up intensity and home health needs. This area is important to providers and payers because targeting follow-up resources to patients at higher risk can reduce preventable readmissions and outpatient emergency care, improving outcomes while controlling post-acute costs.

OpenPayer

Foot Procedures without CC/MCC: Inpatient Reimbursement Overview

Sign up for drg 505 policy alerts

DRG 505 Overview

OpenPayer

Foot Procedures without CC/MCC: Inpatient Reimbursement Overview

Sign up for drg 505 policy alerts

DRG 505 Overview

Clinical Trials

Related Codes

References

Clinical Trials

Related Codes

References